What is Gyre Therapeutics, Inc.'s PP&E (net)?

Gyre Therapeutics, Inc. (GYRE) reported PP&E (net) of $23.57M in Q1 2026.

How has Gyre Therapeutics, Inc.'s PP&E (net) changed year-over-year?

Gyre Therapeutics, Inc.'s PP&E (net) increased by 0.2% year-over-year, from $23.52M to $23.57M.

What is the long-term trend for Gyre Therapeutics, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s PP&E (net) has grown at a 122.5% compound annual growth rate (CAGR), from $433K to $23.6M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Gyre Therapeutics, Inc. GYRE PP&E (Net)

PP&E (Net) at other companies

Eli LillyLLY

$26.54B+43.7%

Madrigal Pharmaceuticals, Inc.MDGL

$8.04M+323%

Theravance BiopharmaTBPH

$5.54M-21.2%

Zevra Therapeutics, Inc.ZVRA

$430K+1.9%

LQD

Liquidia CorporationLQDA

$20.84M+146%

BridgeBio PharmaBBIO

$4.94M-26.2%

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s PP&E (net)?: Gyre Therapeutics, Inc. (GYRE) reported PP&E (net) of $23.57M in Q1 2026.
How has Gyre Therapeutics, Inc.'s PP&E (net) changed year-over-year?: Gyre Therapeutics, Inc.'s PP&E (net) increased by 0.2% year-over-year, from $23.52M to $23.57M.
What is the long-term trend for Gyre Therapeutics, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s PP&E (net) has grown at a 122.5% compound annual growth rate (CAGR), from $433K to $23.6M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.